Piramal Enterprises’ arm enters into agreement to acquire stake in Hemmo

31 Mar 2021 Evaluate

Piramal Enterprises’ subsidiary company -- Piramal Pharma (PPL) has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals (Hemmo) for an upfront consideration of Rs 775 crore and earn-outs linked to achievement of milestones. Consequent to this Acquisition, Hemmo would become a wholly owned subsidiary of PPL. Hemmo is one of India’s largest manufacturers of synthetic peptides with a legacy of more than thirty eight years in business supplying peptide products and custom peptide synthesis.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises Share Price

924.50 16.70 (1.84%)
26-Apr-2024 15:31 View Price Chart
Peers
Company Name CMP
Bajaj Finance 6733.55
Shriram Finance 2509.50
Aditya Birla Capital 232.15
SBI Cards AndPayment 751.70
Chola Invest & Fin. 1174.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.